论文部分内容阅读
痉挛性支气管炎是儿科多发病,常见病,发病率占儿科门诊人数的四分之一,严重威胁着儿童身体健康。目前此病治疗的办法不多,单独使用各种抗菌素的效果不佳,往往要加用肾上腺皮质激素或丙种球蛋白才能取得临床疗效,故考虑此病可能与肾上腺皮质功能低下或机体免疫机能紊乱有关。 1975年7月～12月,我们用人胚注射液治疗痉挛性支气管炎46例,取得一定临床疗效,现小结如下。一般资料 (一)年龄:本组46例,3岁以下32例,3岁以上14例。
Spastic bronchitis is a frequent pediatric disease, common disease, the incidence of pediatric outpatient clinics accounted for a quarter, a serious threat to children’s health. At present, the treatment of the disease is not much, the effect of various antibiotics alone is poor, often with adrenal cortical hormone or gamma globulin in order to achieve clinical efficacy, so consider the disease may be associated with adrenal insufficiency or immune dysfunction related. July 1975 ~ December, we use human embryo injection treatment of spastic bronchitis in 46 cases, achieved a certain clinical efficacy, are summarized as follows. General Information (A) Age: The group of 46 cases, 32 cases under 3 years old, over 3 years of age in 14 cases.